Our AI-driven platform fuses quantum physics, machine learning, and high-performance cloud computing to simulate crystal formation and address one of pharma’s most critical challenges: polymorphism.



The impact? Weeks instead of months. Certainty over guesswork.

Global Pharmaceutical leaders trust us to reduce risk, accelerate timelines, and boost the success rate of new drugs.



Backed by Enterprise Ireland, the EIC Accelerator, and strategic partners like Viridien (formerly CGG), we’re scaling fast.



Follow along as we change how the world brings medicines to life.